AstraZeneca (NASDAQ:AZN) has reported positive results from an analysis of its NIAGARA Phase 3 study of Imfinzi in the treatment of muscle-invasive bladder cancer, or MIBC. The analysis showed that ...
One cancer patient says he probably wouldn’t be here today if it weren’t for getting the test after he was diagnosed with stage four lung cancer.
Right now, our state’s most vulnerable populations that rely on Medicare and Medicaid are unable to access anti-obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback